Absorption of a novel prodrug of L-dopa, L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine (NB-355). In vitro and in situ studies.

A Hisaka; S Kasamatsu; N Takenaga; M Ohtawa

Article Information

vol. 18 no. 5 621-625

PubMed

1981710

Published By

American Society for Pharmacology and Experimental Therapeutics

Print ISSN

0090-9556

Online ISSN

1521-009X

History

Published online September 1, 1990.

Author Information

A Hisaka,
S Kasamatsu,
N Takenaga and
M Ohtawa

Central Research Laboratories, Banyu Pharmaceutical Company, Ltd., Tokyo, Japan.

Statistics from Altmetric.com

Article usage

Article usage: February 1999 to April 2021

	Abstract	Pdf
Feb 1999	1	0
Apr 1999	1	0
Oct 1999	1	0
Nov 1999	2	0
Feb 2000	1	0
Aug 2000	1	0
Mar 2001	1	0
Jul 2001	1	0
Jan 2002	1	0
Jul 2002	1	0
Dec 2002	3	0
Jan 2003	1	0
Feb 2003	3	0
Mar 2003	1	0
Apr 2003	1	0
Jun 2003	1	0
Jul 2003	6	0
Aug 2003	2	0
Sep 2003	8	0
Oct 2003	4	0
Nov 2003	11	0
Dec 2003	7	0
Jan 2004	7	0
Feb 2004	7	0
Mar 2004	4	0
Apr 2004	6	0
May 2004	6	0
Jun 2004	10	0
Jul 2004	13	0
Aug 2004	14	0
Sep 2004	14	0
Oct 2004	13	0
Nov 2004	19	0
Dec 2004	18	0
Jan 2005	22	0
Feb 2005	9	0
Mar 2005	9	0
Apr 2005	4	1
May 2005	10	0
Jun 2005	5	2
Jul 2005	3	0
Aug 2005	3	2
Sep 2005	10	1
Oct 2005	8	2
Nov 2005	19	1
Dec 2005	3	3
Jan 2006	2	0
Feb 2006	4	1
Mar 2006	10	0
Apr 2006	4	0
May 2006	4	3
Jun 2006	9	0
Jul 2006	4	1
Aug 2006	7	1
Sep 2006	6	0
Oct 2006	12	2
Nov 2006	13	1
Dec 2006	6	0
Jan 2007	12	2
Feb 2007	7	2
Mar 2007	14	2
Apr 2007	11	2
May 2007	15	3
Jun 2007	9	1
Jul 2007	7	0
Aug 2007	7	1
Sep 2007	4	1
Oct 2007	17	3
Nov 2007	8	2
Jan 2008	1	1
Feb 2008	1	0
Mar 2008	4	1
Apr 2008	2	1
May 2008	2	1
Jun 2008	5	1
Jul 2008	5	1
Aug 2008	5	0
Sep 2008	14	5
Oct 2008	10	5
Nov 2008	9	8
Dec 2008	6	2
Jan 2009	3	3
Feb 2009	2	5
Mar 2009	7	1
Apr 2009	6	0
May 2009	6	1
Jun 2009	3	1
Jul 2009	5	1
Aug 2009	2	1
Sep 2009	5	3
Oct 2009	6	0
Nov 2009	6	0
Dec 2009	12	0
Jan 2010	4	1
Feb 2010	7	2
Mar 2010	5	1
Apr 2010	7	0
May 2010	8	1
Jun 2010	6	1
Jul 2010	3	0
Aug 2010	4	0
Sep 2010	8	1
Oct 2010	4	0
Nov 2010	6	4
Dec 2010	5	2
Jan 2011	3	2
Feb 2011	4	0
Mar 2011	10	2
Apr 2011	8	0
May 2011	6	4
Jun 2011	2	0
Jul 2011	9	0
Aug 2011	8	1
Sep 2011	18	0
Oct 2011	6	2
Nov 2011	9	1
Dec 2011	6	2
Jan 2012	12	1
Feb 2012	7	0
Mar 2012	11	0
Apr 2012	13	3
May 2012	6	0
Jun 2012	12	5
Jul 2012	7	0
Aug 2012	3	0
Sep 2012	9	1
Oct 2012	10	0
Nov 2012	8	2
Dec 2012	10	2
Jan 2013	23	0
Feb 2013	15	0
Mar 2013	19	1
Apr 2013	8	2
May 2013	10	0
Jun 2013	2	3
Jul 2013	6	1
Sep 2013	9	3
Oct 2013	6	0
Nov 2013	1	2
Dec 2013	4	2
Jan 2014	2	0
Feb 2014	9	0
Mar 2014	4	0
Apr 2014	3	0
Jun 2014	3	3
Jul 2014	5	0
Aug 2014	3	0
Sep 2014	5	0
Oct 2014	2	0
Nov 2014	7	0
Dec 2014	2	0
Jan 2015	2	0
Feb 2015	1	3
Mar 2015	4	0
Apr 2015	6	0
May 2015	3	1
Jun 2015	4	0
Jul 2015	6	0
Aug 2015	7	2
Sep 2015	4	1
Nov 2015	5	1
Dec 2015	26	1
Jan 2016	1	2
Feb 2016	4	0
Mar 2016	6	0
Apr 2016	5	1
Jul 2016	4	3
Aug 2016	5	0
Oct 2016	4	1
Nov 2016	9	3
Dec 2016	1	2
Jan 2017	3	0
Feb 2017	1	0
Mar 2017	9	1
Apr 2017	4	2
May 2017	2	0
Jun 2017	2	1
Jul 2017	6	0
Aug 2017	6	0
Sep 2017	8	0
Oct 2017	23	0
Nov 2017	9	0
Dec 2017	10	0
Jan 2018	6	0
Feb 2018	6	0
Mar 2018	9	1
Apr 2018	2	0
May 2018	9	1
Jun 2018	2	0
Jul 2018	3	0
Sep 2018	2	0
Oct 2018	9	0
Dec 2018	3	0
Jan 2019	7	0
Feb 2019	3	0
Mar 2019	4	0
Apr 2019	4	0
May 2019	9	2
Jun 2019	4	2
Jul 2019	3	1
Aug 2019	11	0
Sep 2019	3	0
Oct 2019	3	0
Nov 2019	9	2
Dec 2019	11	0
Jan 2020	2	0
Feb 2020	4	0
Mar 2020	3	0
Apr 2020	1	0
May 2020	16	1
Jun 2020	4	0
Jul 2020	4	0
Aug 2020	2	0
Sep 2020	5	0
Oct 2020	5	0
Nov 2020	5	1
Dec 2020	7	0
Jan 2021	4	0
Feb 2021	4	0
Mar 2021	13	0
Apr 2021	2	0

In this issue

Download PDF

Article Alerts

Email Article

Citation Tools

Main menu

User menu

Search

Absorption of a novel prodrug of L-dopa, L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine (NB-355). In vitro and in situ studies.

Article Information

Author Information

Statistics from Altmetric.com

Article usage

Article usage: February 1999 to April 2021

In this issue

Absorption of a novel prodrug of L-dopa, L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine (NB-355). In vitro and in situ studies.

Citation Manager Formats

Absorption of a novel prodrug of L-dopa, L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine (NB-355). In vitro and in situ studies.

Related Articles

Cited By...

Similar Articles

Navigate

More Information

ASPET's Other Journals

Main menu

User menu

Search

Absorption of a novel prodrug of L-dopa, L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine (NB-355). In vitro and in situ studies.

Article Information

Author Information

Statistics from Altmetric.com

Article usage

Article usage: February 1999 to April 2021

In this issue

Absorption of a novel prodrug of L-dopa, L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine (NB-355). In vitro and in situ studies.

Citation Manager Formats

Absorption of a novel prodrug of L-dopa, L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine (NB-355). In vitro and in situ studies.

Jump to section

Related Articles

Cited By...

Similar Articles

Navigate

More Information

ASPET's Other Journals